Cellectis
CLLS
63 hedge funds and large institutions have $234M invested in Cellectis in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 14 closing their positions.
107% more capital inflows, than outflows
Capital inflows: $44.7M | Capital outflows: $21.6M
73% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 15
43% more call options, than puts
Call options by funds: $1.42M | Put options by funds: $996K
2.76% more ownership
Funds ownership: 25.26% → 28.02% (+2.8%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
3% less funds holding
Funds holding: 65 → 63 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nikko Asset Management Americas
New York
|
+$14.6M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$14.5M |
| 3 |
Capital Guardian Trust
Los Angeles,
California
|
+$4.32M |
| 4 |
ARK Investment Management
St. Petersburg,
Florida
|
+$3.89M |
| 5 |
Armistice Capital
New York
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.58M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$3.99M |
| 3 |
Axa
Paris,
France
|
-$2.76M |
| 4 |
Rubric Capital Management (New York)
New York
|
-$1.99M |
| 5 |
Abingworth
London,
United Kingdom
|
-$1.66M |
CLLS Hedge Fund Activity: Q1 2019 in Review
63 of the 4,634 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2019, worth a combined $234M — up 22% from $191M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CLLS and 13 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 26 added.
The largest buyer was Nikko Asset Management Americas, opening a new position worth an estimated $14.6M. The largest seller was Point72 Asset Management, cutting an estimated $5.58M.
- 63 institutional investors held Cellectis (CLLS) as of Q1 2019, down from 65 in Q4 2018.
- Funds reported $234M of Cellectis stock for Q1 2019, up 22% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q1 2019 and 14 closed out, a net change of -1 holder.
- The largest Cellectis buyer in Q1 2019 was Nikko Asset Management Americas, an estimated $14.6M added.
- The largest Cellectis seller in Q1 2019 was Point72 Asset Management, an estimated $5.58M sold.
Based on aggregated 13F filings for Q1 2019.